Influence of Mast Cells on Dengue Protective Immunity and Immune Pathology

PLoS Pathogens

Volumn 9, Issue 12, 2013, Pages 1-4

  St John, Ashley L ^a,b  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD48 ANTIGEN; FC RECEPTOR; PATTERN RECOGNITION RECEPTOR; TUMOR NECROSIS FACTOR;

ARTICLE; CYTOKINE STORM; DENGUE; DENGUE VIRUS; HUMAN; HYPOVOLEMIC SHOCK; IMMUNITY; IMMUNOLOGICAL MEMORY; IMMUNOPATHOLOGY; IMMUNOSURVEILLANCE; LANGERHANS CELL; MAST CELL; MAST CELL DEGRANULATION; MEMORY T LYMPHOCYTE; NONHUMAN; TISSUE INJURY; ACTIVE IMMUNIZATION; ANIMAL; IMMUNOLOGY; PHYSIOLOGY; VASCULAR DISEASE; VIROLOGY;

ANIMALS; DENGUE; DENGUE VIRUS; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNITY, ACTIVE; IMMUNOLOGIC MEMORY; IMMUNOLOGIC SURVEILLANCE; MAST CELLS; SEVERE DENGUE; VASCULAR DISEASES;

EID: 84892885058     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003783     Document Type: Article

References (20)

1. Abraham SN, St.John AL, (2010) Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 10: 440-452.
2. St. John AL, Abraham SN, (2013) Innate immunity and its regulation by mast cells. J Immunol 190: 4458-4463.
3. Piliponsky AM, Chen CC, Grimbaldeston MA, Burns-Guydish SM, Hardy J, et al. (2010) Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice. Am J Pathol 176: 926-938.
4. Halstead SB, (2007) Dengue. Lancet 370: 1644-1652.
5. Choumet V, Attout T, Chartier L, Khun H, Sautereau J, et al. (2012) Visualizing non infectious and infectious Anopheles gambiae blood feedings in naive and saliva-immunized mice. PLoS ONE 7: e50464. doi:10.1371/journal.pone.0050464.
6. Wu SJ, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, et al. (2000) Human skin Langerhans cells are targets of dengue virus infection. Nat Med 6: 816-820.
7. St. John AL, Rathore AP, Yap H, Ng ML, Metcalfe DD, et al. (2011) Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc Natl Acad Sci U S A 108: 9190-9195.
8. St. John AL, Rathore AP, Raghavan B, Ng ML, Abraham SN, (2013) Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. eLife 2: e00481.
9. Nilsson G, Johnell M, Hammer CH, Tiffany HL, Nilsson K, et al. (1996) C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 157: 1693-1698.
10. Demeure CE, Brahimi K, Hacini F, Marchand F, Peronet R, et al. (2005) Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia. J Immunol 174: 3932-3940.
11. Kunder CA, St. John AL, Abraham SN, (2011) Mast cell modulation of the vascular and lymphatic endothelium. Blood 118: 5383-5393.
12. Chan M, Johansson MA, (2012) The incubation periods of dengue viruses. PLoS ONE 7: e50972. doi:10.1371/journal.pone.0050972.
13. St. John AL, Abraham SN, Gubler DJ, (2013) Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis. Nat Rev Microbiol 11: 420-426.
14. Rothman AL, (2011) Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11: 532-543.
15. Zellweger RM, Prestwood TR, Shresta S, (2010) Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe 7: 128-139.
16. Halstead SB, O'Rourke EJ, (1977) Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265: 739-741.
17. Balsitis SJ, Williams KL, Lachica R, Flores D, Kyle JL, et al. (2010) Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog 6: e1000790. doi:10.1371/journal.ppat.1000790.
18. Sanchez LF, Hotta H, Hotta S, Homma M, (1986) Degranulation and histamine release from murine mast cells sensitized with dengue virus-immune sera. Microbiol Immunol 30: 753-759.
19. King CA, Marshall JS, Alshurafa H, Anderson R, (2000) Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J Virol 74: 7146-7150.
20. Koraka P, Murgue B, Deparis X, Setiati TE, Suharti C, et al. (2003) Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity. J Med Virol 70: 91-98.